Within the European Horizon 2020 project BioRECO2VER, an international consortium will take an important step in making bioconversion of CO2 commercially feasible. The 4 year project, coordinated by VITO, kicked off in January 2018 and will focus on refining biotechnological processes which can turn CO2 from industrial point sources into valuable platform chemicals like lactate and isobutene. The impact of the BioRECO2VER project is to provide an important next step in valorizing CO2, while at the same time offering alternative solutions for the production of chemicals.
The project goal is to create alternative processes for commercial-scale production of platform chemicals in a more sustainable way starting from industrial emissions of CO2. However, we still need to overcome some technical and economic barriers, from which biotechnological processes for CO2 conversion suffer. To name a few: gas pretreatment costs are still too high, gas transfer in the bioreactors is suboptimal, product recovery costs are still too elevated, and the scalability has not sufficiently been proven.